ong term follow-up of the effect of Constant Positive Airway Pressure treatment on blood glucose control in patients with type 2 diabetes mellitus and obstructive sleep apnoea (GLYCOSA follow-up study)

Not Applicable

Completed

• Conditions: type 2 diabetes; obstructive sleep apnoea; Metabolic and Endocrine - Diabetes; Respiratory - Sleep apnoea

• Registration Number: ACTRN12612000246886
• Lead Sponsor: ResMed Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-28
• Study Completion: 2013-05-01
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

People over the age of 18 with T2D and OSA, who have taken part in the GLYCOSA study

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Participants with diagnosed type 2 diabetes (T2D) and obstructive sleep apnoea (OSA) will show sustained improvement in their glycaemic control following previous intensive use of Constant Positive Airway Pressure (CPAP) therapy. Participants will have a blood sample taken to measure the HbA1c level. Also, participants will be required to perform a 7-point blood glucose monitoring on two days.[ Follow-up of participants involved in the GLYCOSA study and randomised between 2007 and 2011. There will be 2 visits in total for each participant. Anticipated commencement date of this study 01/04/2012. Anticipated completion date of this study 01/03/2013. Therefore, participants will be followed-up anywere between 1 and 5 years post randomisation in the GLYCOSA study.]